Terms: = Colorectal cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Treatment
6 results:
1. G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon cancer.
Ray AL; Saunders AS; Nofchissey RA; Reidy MA; Kamal M; Lerner MR; Fung KM; Lang ML; Hanson JA; Guo S; Urdaneta-Perez MG; Lewis SE; Cloyde M; Morris KT
Clin Cancer Res; 2023 Jun; 29(11):2158-2169. PubMed ID: 36951682
[TBL] [Abstract] [Full Text] [Related]
2. Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
Saunders AS; Bender DE; Ray AL; Wu X; Morris KT
PLoS One; 2021; 16(2):e0247233. PubMed ID: 33606788
[TBL] [Abstract] [Full Text] [Related]
3. [Preliminary report on prospective, multicenter, open research of selective surgery after expandable stent combined with neoadjuvant chemotherapy in the treatment of obstructive left hemicolon cancer].
Han J; Wang Z; Dai Y; Li X; Qian Q; Wang G; Wei G; Zeng W; Ma L; Zhao B; Wang Y; Yang K; Ding Z; Hu X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1233-1239. PubMed ID: 30506533
[TBL] [Abstract] [Full Text] [Related]
4. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
[TBL] [Abstract] [Full Text] [Related]
5. Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective data.
Klein M; Gögenur I; Rosenberg J
BMJ; 2012 Sep; 345():e6166. PubMed ID: 23015299
[TBL] [Abstract] [Full Text] [Related]
6. Radical surgery of colon cancers directly invading the duodenum, pancreas and liver.
Kama NA; Reis E; Doganay M; Gozalan U; Yasti C
Hepatogastroenterology; 2001; 48(37):114-7. PubMed ID: 11268944
[TBL] [Abstract] [Full Text] [Related]
